The Drosophila Tumour Suppressor Lgl and Vap33 activate the Hippo pathway by a dual mechanism, involving RtGEF/Git/Arf79F and inhibition of the V-ATPase. https://www.biorxiv.org/content/10.1101/2023.07.10.548302v1?med=mas
The Drosophila Tumour Suppressor Lgl and Vap33 activate the Hippo pathway by a dual mechanism, involving RtGEF/Git/Arf79F and inhibition of the V-ATPase. https://www.biorxiv.org/content/10.1101/2023.07.10.548302v1?med=mas